ClinicalTrials.Veeva

Menu
W

Wagner Macula & Retina Center | Norfolk, VA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Faricimab
Ranibizumab
Lampalizumab
YD312
THR-149
CBT-001
Eplerenone

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 16 total trials

A Clinical Trial on Safety and Efficacy of CBT-001 in Patients With Pterygium

The objective is to evaluate the safety and efficacy of low dose and high dose CBT-001 eye drop dosed twice daily for 24 months compared to vehicle i...

Enrolling
Pterygium
Drug: CBT-001
Drug: Vehicle

ABBV-RGX-314 (also known as RGX-314) is being developed as a novel one-time gene therapy for the treatment of neovascular (wet) age-related macular d...

Enrolling
Wet Age-related Macular Degeneration
WetAMD
Biological: Aflibercept (EYLEA®)
Genetic: ABBV-RGX-314 Dose 2

Trial sponsors

Roche logo
Genentech logo
AbbVie logo
C
Notal Vision logo
Oxurion logo
S
Y
W

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems